Affordable Access

Declaración del Comité Consultivo de Inmunizaciones de la Sociedad Chilena de Infectología respecto a la vacuna anti-virus papiloma humano. Septiembre 2008

Revista médica de Chile
SciELO Comision Nacional de Investigacion Cientifica Y Tecnologica
Publication Date
  • Randomized Controlled-Trial
  • Particle Vaccine
  • Young-Women
  • Quadrivalent Vaccine
  • Double-Blind
  • Vlp Vaccine
  • Hpv Types
  • Type-18
  • Efficacy
  • Prevalence
  • Biology
  • Medicine


This article briefly reviews the epidemiology of human papillomavirus (HPV) infection and associated diseases globally and in Chile, and the scientific information of the licensed HPV vaccines: Garadasil (R) and Cervarix (R). Considering the available information, the Advisory Committee on Immunizations of the Chilean Society of Infectious Diseases recommends vaccination of teenage girls, ideally before initiating sexual activity, i.e. approximately at the age of 12 to 13 years and vaccination of women of any age if they have not started sexual activity. If women are vaccinated after initiating sexual activity, they should be informed of the lower efficacy of immunization if HPV infection has occurred. Education on responsible sexuality and sexually transmitted diseases should be maintained as a priority. Vaccination should be highly considered for inclusion in the National Immunization Program

There are no comments yet on this publication. Be the first to share your thoughts.